Researchers in China may have uncovered a surprising ally in the fight against sugar cravings and metabolic disorders: a ...
FGF21 is a mediator of the fasting response ... This Review discusses traditional applications of recombinant FGFs and small-molecule FGF receptor kinase inhibitors in the treatment of cancer ...
After missing the primary endpoint in the Phase IIb SYMMETRY trial, Akero Therapeutics’ lead molecule, efruxifermin, showed ...
The proposed model for nonethanol ingredient ethyl lactate-mediated hepatic FGF21 activation in inhibiting the pathogenesis of ALD in mice. Credit: Advanced Science (2024). DOI: 10.1002/advs.202409516 ...